SULFONYLUREAS - EFFECTS IN-VIVO AND IN-VITRO

[1] ARDLIE NG, 1967, THROMB DIATH HAEMOST, V18, P670

[2] ASHMORE J, 1956, METABOLISM, V5, P774

[3] 9 YEARS EXPERIENCE WITH TOLBUTAMIDE IN TREATMENT OF DIABETES [J]. METABOLISM, 1966, 15 (11): : 957 - +

[4] POTENTIATION OF ANTIDIURETIC EFFECT OF VASOPRESSIN BY CHLORPROPAMIDE [J]. ENDOCRINOLOGY, 1970, 86 (05) : 1028 - &

[5] BLOODWORTH JMB, 1963, METABOLISM, V12, P287

[6] BORSTEIN J, 1957, NATURE, V179, P534

[7] BLOOD DYSCRASIAS ASSOCIATED WITH TOLBUTAMIDE THERAPY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 171 (03): : 296 - 297

[8] CHLORPROPAMIDE AND TOLBUTAMIDE INHIBITION OF ADENOSINE 3'5' CYCLIC MONOPHOSPHATE PHOSPHODIESTERASE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1971, 42 (05) : 824 - &

[9] BROWN J, 1956, METABOLISM, V5, P813

[10] BUTCHER RW, 1962, J BIOL CHEM, V237, P1244

[1] ARDLIE NG, 1967, THROMB DIATH HAEMOST, V18, P670

[2] ASHMORE J, 1956, METABOLISM, V5, P774

[3] 9 YEARS EXPERIENCE WITH TOLBUTAMIDE IN TREATMENT OF DIABETES [J]. METABOLISM, 1966, 15 (11): : 957 - +

[4] POTENTIATION OF ANTIDIURETIC EFFECT OF VASOPRESSIN BY CHLORPROPAMIDE [J]. ENDOCRINOLOGY, 1970, 86 (05) : 1028 - &

[5] BLOODWORTH JMB, 1963, METABOLISM, V12, P287

[6] BORSTEIN J, 1957, NATURE, V179, P534

[7] BLOOD DYSCRASIAS ASSOCIATED WITH TOLBUTAMIDE THERAPY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 171 (03): : 296 - 297

[8] CHLORPROPAMIDE AND TOLBUTAMIDE INHIBITION OF ADENOSINE 3'5' CYCLIC MONOPHOSPHATE PHOSPHODIESTERASE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1971, 42 (05) : 824 - &

[9] BROWN J, 1956, METABOLISM, V5, P813

[10] BUTCHER RW, 1962, J BIOL CHEM, V237, P1244